Results

Total Results: 19 records

Showing results for "glycosides".

1. SRDR - Systematic Review Data Repository |
   srdr.ahrq.gov/projects/1312/studies/133143
   January 01, 2015 - (quercetin-3-glycosides was the third capsule group; I did not include them in this extraction)

2. Misread Label | PSNet
   psnet.ahrq.gov/web-mm/misread-label
   March 01, 2004 - Misread Label Save Save to your library Print Share Facebook Twitter Linkedin Copy URL Bryony Dean Franklin, PhD | November 1, 2003 View more articles from the same authors. The Case An infant was born with sluggish respirations. During labor…

3. Type of Drug & ADE (by drug-type) (pdf file)
   hcup-us.ahrq.gov/reports/statbriefs/sb158_appendix.pdf
   September 23, 2013 - Descriptions Page 14 of 22 Cardiovascular drugs Digoxin 972.1 Poisoning by cardiotonic glycosides … and drugs of similar action E942.1 Cardiotonic glycosides and drugs of similar action causing adverse

4. Appendix - Adverse Drug Events in U.S. Hospitals, 2010 Versus 2014 (pdf file)
   hcup-us.ahrq.gov/reports/statbriefs/sb234-appendix.pdf
   January 01, 2014 - Descriptions Page 14 of 22 Cardiovascular drugs Digoxin 972.1 Poisoning by cardiotonic glycosides … and drugs of similar action E942.1 Cardiotonic glycosides and drugs of similar action causing adverse

5. Statistical Brief #109: Medication-Related Adverse Outcomes in U.S. Hospitals and Emergency Departments, 2008 (pdf file)
   hcup-us.ahrq.gov/reports/statbriefs/sb109.pdf
   April 01, 2011 - antihypertensive agents (e.g., clonidine, guanethidine, reserpine) 48,800 2.3% 14,300 1.4% Cardiotonic glycosides … antihypertensive agents (e.g., clonidine, guanethidine, reserpine) 972.6, E942.6 Cardiotonic glycosides

6. Statistical Brief #109
   hcup-us.ahrq.gov/reports/statbriefs/sb109.jsp
   April 01, 2011 - e.g., clonidine, guanethidine, reserpine) 48,800 2.3% 14,300 1.4%     Cardiotonic glycosides … antihypertensive agents (e.g., clonidine, guanethidine, reserpine) 972.6, E942.6 Cardiotonic glycosides

7. Statistical Brief #29
   hcup-us.ahrq.gov/reports/statbriefs/sb29.jsp
   April 01, 2007 - agents (e.g., clonidine, guanethidine, reserpine) 42,800 3.5% 3,600 2.3% Cardiotonic glycosides

8. HCUP Statistical Brief #29: Adverse Drug Events in U.S. Hospitals, 2004 (pdf file)
   hcup-us.ahrq.gov/reports/statbriefs/sb29.pdf
   April 01, 2007 - antihypertensive agents (e.g., clonidine, guanethidine, reserpine) 42,800 3.5% 3,600 2.3% Cardiotonic glycosides

9. Sb216-Appendix (pdf file)
   hcup-us.ahrq.gov/reports/statbriefs/sb216-appendix.pdf
   October 01, 2004 - use E942.0 Cardiac rhythm regulators causing adverse effects in therapeutic use E942.1 Cardiotonic glycosides

10. Agency for Healthcare Research and Quality
    www.ahrq.gov/research/findings/studies/index.html?page=464
    January 01, 2024 - AHRQ Research Studies Sign up: AHRQ Research Studies Email updates Research Studies is a compilation of published research articles funded by AHRQ or authored by AHRQ researchers. Results 11601 to 11625 of 12077 Research Studies Displayed Pagination « first « First ‹ previous ‹‹ …

11. Appendix 247 - Opioid-Related Hospital Stays Among Women in the United States, 2016 (pdf file)
    hcup-us.ahrq.gov/reports/statbriefs/sb247-appendix.pdf
    January 14, 2019 - hematological agent, intentional self-harm, initial encounter T46.0X2A Poisoning by cardiac-stimulant glycosides

12. Psi 08 In Hospital Fall With Hip Fracture Rate (pdf file)
    qualityindicators.ahrq.gov/Downloads/Modules/PSI/v2019/TechSpecs/PSI_08_In_Hospital_Fall_with_Hip_Fracture_Rate.pdf
    July 01, 2019 - anesthetics, accidental (unintentional), initial encounter T460X1A Poisoning by cardiac-stimulant glycosides … Poisoning by local anesthetics, assault, initial encounter T460X3A Poisoning by cardiac-stimulant glycosides … Poisoning by local anesthetics, undetermined, initial encounter T460X4A Poisoning by cardiac-stimulant glycosides

13. Psi 08 In Hospital Fall With Hip Fracture Rate (pdf file)
    qualityindicators.ahrq.gov/Downloads/Modules/PSI/v2020/TechSpecs/PSI_08_In_Hospital_Fall_with_Hip_Fracture_Rate.pdf
    March 01, 2021 - anesthetics, accidental (unintentional), initial encounter T460X1A Poisoning by cardiac-stimulant glycosides … Poisoning by local anesthetics, assault, initial encounter T460X3A Poisoning by cardiac-stimulant glycosides … Poisoning by local anesthetics, undetermined, initial encounter T460X4A Poisoning by cardiac-stimulant glycosides

14. HCUPanalysisPedEDVisitsSuicide (pdf file)
    hcup-us.ahrq.gov/reports/ataglance/HCUPanalysisPedEDVisitsSuicide.pdf
    November 05, 2019 - hematological agent, intentional self-harm, initial encounter T46.0X2A Poisoning by cardiac-stimulant glycosides

15. Final Progress Report: Improving Patient Safety by Reducing Medication Errors (pdf file)
    www.ahrq.gov/sites/default/files/2024-03/strom2-report.pdf
    January 01, 2024 - projects also aimed to target selected high-risk drugs (e.g., anticoagulants, anticonvulsants, digitalis glycosides

16. Final Progress Report: Improving Patient Safety by Reducing Medication Errors (pdf file)
    ce.effectivehealthcare.ahrq.gov/sites/default/files/2024-03/strom2-report.pdf
    January 01, 2024 - projects also aimed to target selected high-risk drugs (e.g., anticoagulants, anticonvulsants, digitalis glycosides

17. Comparative Effectiveness of Dietary Supplement Versus No Dietary Supplement Use in Adults Taking Cardiovascular Drugs | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/dietary-supplements/research-protocol
    December 21, 2010 - This enzyme is involved in the oxidative metabolism of many synthetic drugs, 14-20 including cardiac glycosides

18. Sb249-Appendix (pdf file)
    hcup-us.ahrq.gov/reports/statbriefs/sb249-appendix.pdf
    March 18, 2019 - hematological agent, intentional self-harm, initial encounter T460X2A Poisoning by cardiac-stimulant glycosides

19. Evidence Report on the (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/dietary-supplements_research-protocol.pdf
    December 15, 2010 - This enzyme is involved in the oxidative metabolism of many synthetic drugs,14-20 including cardiac glycosides